Cybin is a company which focuses on the production and marketing of medical cannabis. It was listed in the Alt-X of the JSE 25th June 2024 as a special purpose acquisition company (SPAC) and plans to acquire Cilo Cybin Pharmaceutical. Cilo Cybin is to make 10% of its 71m ordinary shares available to the market - which probably means it will be very thinly traded at least to begin with. The company's CEO is Gabriel Theron.
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。